Economic Recovery Insights
A discussion on the critical need for effective stimulus measures and increased funding for scientific research emerges, especially in the wake of health crises. The conversation highlights the challenges entrepreneurs face in the pharmaceutical industry, particularly regarding the lengthy and costly FDA approval process. Additionally, personal immune-boosting strategies are shared, emphasizing the importance of maintaining health during uncertain times.In this clip
From this podcast
The James Altucher Show
563 - The GOOD News About Coronavirus (Let's Look at the Data) with Peter Diamandis, XPRIZE Founder & Futurist
Related Questions